Physician profile
Kyle G Achors
NPI 1760916985
$9,159.27
in general payments reported to CMS, 2019-2025
9 companies · $1,814 in 2025
The $1,814 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,235 · 2022: $587 · 2023: $5,169 · 2024: $355 · 2025: $1,814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,498 · Food and Beverage: $2,339 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,498.19 |
| Food and Beverage | $2,339.14 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,393.98 | 2022-2025 | Blueprint Patient Specific Instrumentation, Aequalis Perform Reversed, Aequalis Ascend Flex |
| Encore Medical, LP | $2,886.80 | 2023-2025 | Djo Surgical |
| Mvp Orthopedics INC | $1,235.01 | 2021 | |
| Shoulder Innovations, INC. | $215.59 | 2024 | Inset System |
| Depuy Synthes Sales INC. | $137.80 | 2023-2024 | Attune, Va-Lcp |
| Paladin Technology Solutions | $85.05 | 2022 | |
| Smoky Mountain Surgical LLC | $81.63 | 2024-2025 | |
| Smith+Nephew, INC. | $65.13 | 2023 | Healicoil |
| Ethicon US, LLC | $58.28 | 2024 | Vistaseal, Surgiflo Hemostatic Matrix, Ethicon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Achors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.